Ian Benouis

Earth medicines and self-surrender to source saved my life. The goal of the mystical experience is altered traits not altered states. Huston Smith. Nature loves courage. Terence McKenna. Ask the plants of the earth and they will teach you. Job 12:8. If you see the day of judgement coming finish planting a tree. Muhammad

The time has come. The DEA must immediately deschedule 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) from Schedule I of the Controlled Substances Act. The 2011 permanent scheduling (following the 2004 emergency placement) was built on outdated, incomplete science, anecdotal overreach, and a failure to adapt to emerging evidence. Today, with overwhelming evidence of endogenous human production, demonstrated safety, no […]

Meet Ian Benouis a West Point Graduate, Former U.S. Army Officer, Black Hawk Pilot, Intellectual Property Attorney & American Muslim Activist. In this wide ranging interview we cover everything from fighting to reduce veteran suicides, self forgiveness, building bridges between communities, the movement to legalize natural medicines to treat PTSD, the various types of trauma that impact human beings, and how Ian’s understanding of Islam encourages him to grow as a person and help others.

This conversation explores various aspects of cannabis culture, psychedelic experiences, and conservation efforts. The speakers discuss their experiences at the Terpene Ball, the cannabis scene in Tennessee, and the Enigma Gathering. They delve into the importance of conservation for toads, the debate between synthetic and natural psychedelics, and the role of love and responsibility in these experiences. The conversation also touches on the energetic imprint of medicines and the future of psychedelics, emphasizing the need for personal connection and understanding in the use of these substances.

In this conversation, Mitch Schultz and Ian Benouis explore the transformative power of plant medicines, particularly in the context of healing trauma experienced by veterans. They discuss their personal journeys with psychedelics, the importance of community and support in the healing process, and the potential for these medicines to help individuals reconnect with their true selves. The conversation emphasizes the need for a holistic approach to healing that integrates both traditional and modern practices, and the role of veterans in leading this change in society.

In a discussion about Psilomethoxin, Gabe, Ben, Ian and Ryan explore its unique properties, effects compared to traditional psychedelics, and potential benefits for veterans. They emphasize community drug development for accessible healing, the evolving psychedelic industry, and the impact of patents on substance availability. Psilomethoxin serves as both an on-ramp and off-ramp for psychedelic experiences.

keywords veteran trauma, psychedelics, healing, mental health, psilomethoxin, gut health, PTSD, natural medicine, community support, citizen science hashtags#psilomethoxin#sacredsynthesis#toadshrooms#bufoboomers#churchofpsilomethoxin#toadally#hikrodosing#psilotoad#toadstool#🐸🍄 summary In this episode, the hosts discuss the profound impact of veteran trauma and the potential healing properties of psychedelics, particularly psilomethoxin. They explore personal stories of trauma, the importance of gut health, and the mental health […]

In the inaugural episode of the Tryptamine Cowboy Chronicles, hosts Ian Benouis, Gabe Hardy, and Ben Moore discuss the Church of the Sacred Synthesis’ mission focused on the healing properties of psychedelics, particularly Psilomethoxin. They highlight the importance of community in accessing these substances and address legal challenges around psychedelic therapies. The hosts share personal experiences, emphasizing the potential of Psilomethoxin for treating PTSD, especially among veterans. They aim to create a pre-order model to bring Psilomethoxin to market as an over-the-counter supplement. Emphasizing transparency and community involvement, the episode encourages listeners to learn and participate in this healing journey.

“these data suggest that R-MDMA could be a more viable therapeutic option for the treatment of PTSD and other disorders for which S/R-MDMA is currently being investigated” since “R-MDMA unlike racemic MDMA, did not increase locomotor activity, produce signs of neurotoxicity, or increase body temperature.

A key pharmacological difference between R-MDMA and racemic MDMA is that R-MDMA has much lower potency as a dopamine releaser. Together, these results indicate that the prosocial and therapeutic effects of S/R-MDMA may be SEPARABLE from the stimulant, thermogenic, and potential neurotoxic effects.”

The authors make the claim that the enzymatic reactions that produce psilocin are “unexpected” for 5-MeO-DMT and therefore the synthesis of psilomethoxin is “unsubstantiated.”  The authors are ignoring the 1988 study by Jochen Gartz where the transformation of diethyl‐tryptamine into 4‐hydroxy‐N,N‐diethyltryptamine (3.3%) and a minor quantity of 4‐phosphoryloxy‐N,N‐diethyltryptamine (≤0.8%) was produced by the Psilocybe cubensis mushroom in an example of biosynthesis of tryptamines.  This IS a peer-reviewed article:  Gartz J. Biotransformation of tryptamine derivatives in mycelial cultures of Psilocybe. Journal of basic microbiology. 1989;29(6):347-52.